The proposed bill, known as the Community Pharmacy Protection Act, aims to amend section 3902.50 and enact new sections 3902.75, 3902.76, and 3959.151 of the Revised Code. Key provisions include limiting the accreditation requirements imposed by health plan issuers on pharmacies, ensuring that these requirements align with those set by the state board of pharmacy. Additionally, the bill establishes a framework for pharmacy benefit managers (PBMs) to report drug costs, requiring them to submit quarterly electronic reports detailing drug claims processed, including maximum allowable costs and actual acquisition costs for each drug. The bill also prohibits retaliation against pharmacies that report violations or exercise their rights under this legislation.

Furthermore, the bill outlines the process for evaluating complaints against health plan issuers regarding violations of the new accreditation standards. If a violation is found, the superintendent of insurance can issue a notice and impose administrative penalties. The act also includes provisions for pharmacies to file formal complaints and provides protections against retaliatory actions by PBMs. The existing section 3902.50 is repealed, and the new sections will apply to health benefit plans and contracts entered into or modified after the effective date of the act.

Statutes affected:
As Introduced: 3902.50